Delivery Order SPE2DB20D2001-SPE2DB25FPNVE
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 11, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,275.62. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 per unit, with a ceiling value of $2,435.67. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.63 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) on August 13, 2025, with completion expected by August 14, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract mechanism and represents a routine pharmaceutical procurement for federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a firm fixed price of $1,332.35. This delivery order, issued without set-aside designation, is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 with a ceiling value of $3,899.83. This contract utilizes a firm fixed price structure with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a firm fixed price of $1,220.68. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and is scheduled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units, with a ceiling value of $1,109.30. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed price contract with a ceiling value of $3,600.48. This non-set-aside, competitively awarded delivery order is set for ultimate completion on August 11, 2025, and represents a continuation of the company's pharmaceutical supply support to federal healthcare systems. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Azathioprine 50 mg tablets (100 count) with a ceiling value of $1,780.72. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,056.22. This non-competitive, firm fixed-price delivery order is set to be completed by August 4, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement under the company's...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNVEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $4,156.24 and an ultimate completion date of September 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle valued through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military healthcare systems and other government agencies. The delivery order aligns with the company's primary role within DLA's medical supply chain, providing both brand-name and generic medications across multiple therapeutic domains to support defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/25/25 |